EA201500327A1 - Неинвазивное определение метилома плода или опухоли по плазме - Google Patents

Неинвазивное определение метилома плода или опухоли по плазме

Info

Publication number
EA201500327A1
EA201500327A1 EA201500327A EA201500327A EA201500327A1 EA 201500327 A1 EA201500327 A1 EA 201500327A1 EA 201500327 A EA201500327 A EA 201500327A EA 201500327 A EA201500327 A EA 201500327A EA 201500327 A1 EA201500327 A1 EA 201500327A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methylation
fetal
tumor
dna
determined
Prior art date
Application number
EA201500327A
Other languages
English (en)
Russian (ru)
Inventor
Росса Вай Квун Чиу
Кван Чи Чань
Юйк-Мин Деннис Ло
Мю Фань Лунь
Пэйюн Цзян
Вай Мань Чань
Original Assignee
Те Чайниз Юниверсити Ов Гонконг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50340462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201500327(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/842,209 external-priority patent/US9732390B2/en
Application filed by Те Чайниз Юниверсити Ов Гонконг filed Critical Те Чайниз Юниверсити Ов Гонконг
Publication of EA201500327A1 publication Critical patent/EA201500327A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
EA201500327A 2012-09-20 2013-09-20 Неинвазивное определение метилома плода или опухоли по плазме EA201500327A1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261703512P 2012-09-20 2012-09-20
US13/842,209 US9732390B2 (en) 2012-09-20 2013-03-15 Non-invasive determination of methylome of fetus or tumor from plasma
US201361830571P 2013-06-03 2013-06-03
PCT/AU2013/001088 WO2014043763A1 (en) 2012-09-20 2013-09-20 Non-invasive determination of methylome of fetus or tumor from plasma

Publications (1)

Publication Number Publication Date
EA201500327A1 true EA201500327A1 (ru) 2015-07-30

Family

ID=50340462

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201500327A EA201500327A1 (ru) 2012-09-20 2013-09-20 Неинвазивное определение метилома плода или опухоли по плазме

Country Status (28)

Country Link
EP (6) EP4335929B1 (https=)
JP (6) JP6317354B2 (https=)
KR (5) KR102148547B1 (https=)
CN (2) CN117757932A (https=)
AU (5) AU2013317708C1 (https=)
BR (3) BR122021021823B1 (https=)
CA (2) CA2884066C (https=)
CY (1) CY1124139T1 (https=)
DK (4) DK4056712T3 (https=)
EA (1) EA201500327A1 (https=)
ES (5) ES2862726T3 (https=)
FI (2) FI3536807T3 (https=)
HR (3) HRP20240210T1 (https=)
HU (3) HUE068129T2 (https=)
IL (4) IL313451A (https=)
LT (2) LT3354747T (https=)
MX (1) MX360034B (https=)
MY (2) MY187444A (https=)
NZ (2) NZ717423A (https=)
PH (2) PH12022552061A1 (https=)
PL (5) PL3536807T3 (https=)
PT (4) PT2898100T (https=)
SG (2) SG11201501927VA (https=)
SI (1) SI4056712T1 (https=)
SM (1) SMT202100256T1 (https=)
TW (5) TWI707953B (https=)
WO (1) WO2014043763A1 (https=)
ZA (1) ZA201501772B (https=)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI335354B (en) 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
BR122021021823B1 (pt) 2012-09-20 2023-04-25 The Chinese University Of Hong Kong Método para determinar um primeiro perfil de metilação de uma amostra biológica de um organismo, e, meio de armazenamento de memória
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3029148B1 (en) * 2013-07-30 2018-06-27 BGI Genomics Co., Limited Method for determining nucleic acid composition of nucleic acid mixture
US10174375B2 (en) 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
WO2015126840A1 (en) * 2014-02-18 2015-08-27 Bionano Genomics, Inc. Improved methods of determining nucleic acid structural information
EP3957749A1 (en) * 2014-04-21 2022-02-23 Natera, Inc. Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
WO2015169947A1 (en) 2014-05-09 2015-11-12 Lifecodexx Ag Detection of dna that originates from a specific cell-type and related methods
WO2016010401A1 (ko) * 2014-07-18 2016-01-21 에스케이텔레콘 주식회사 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법
ES2741400T3 (es) * 2014-07-18 2020-02-10 Univ Hong Kong Chinese Análisis de patrones de metilación de tejidos en mezcla de ADN
CN107002122B (zh) 2014-07-25 2023-09-19 华盛顿大学 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法
WO2016109452A1 (en) * 2014-12-31 2016-07-07 Guardant Health , Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
US10364467B2 (en) * 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
EP3256605B1 (en) * 2015-02-10 2022-02-09 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
EP4063517B1 (en) 2015-07-20 2026-01-07 The Chinese University Of Hong Kong Methylation pattern analysis of haplotypes in cell-free dna mixtures of maternal and fetal dna
IL305462A (en) * 2015-07-23 2023-10-01 Univ Hong Kong Chinese DNA fragmentation pattern analysis suitable clean
CA2995422A1 (en) 2015-08-12 2017-02-16 The Chinese University Of Hong Kong Single-molecule sequencing of plasma dna
CN108026576B (zh) 2015-09-22 2022-06-28 香港中文大学 通过母亲血浆dna的浅深度测序准确定量胎儿dna分数
US10260088B2 (en) 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
US20180327825A1 (en) * 2015-11-09 2018-11-15 Progenity, Inc. Methods for determining the origin of dna molecules
HUE050491T2 (hu) 2015-11-10 2020-12-28 Eurofins Lifecodexx Gmbh Magzati kromoszomális aneuploidiák kimutatása olyan DNS régiókat alkalmazva, amelyek különbözõképpen vannak metilezve a magzat és a terhes nõstény között
EP3390657B1 (en) * 2015-12-17 2020-09-16 Illumina, Inc. Distinguishing methylation levels in complex biological samples
CN109072309B (zh) * 2016-02-02 2023-05-16 夸登特健康公司 癌症进化检测和诊断
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
EP4488686A3 (en) * 2016-04-14 2025-04-30 Guardant Health, Inc. Methods for early detection of cancer
CN109415763A (zh) 2016-05-03 2019-03-01 大学健康网络 捕获无细胞的甲基化dna的方法及其用途
CA3023335A1 (en) * 2016-05-04 2017-11-30 Queen's University At Kingston Cell-free detection of methylated tumour dna
AU2017274038B2 (en) * 2016-05-30 2023-03-16 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free DNA in blood
US20220076779A1 (en) * 2016-06-16 2022-03-10 The Johns Hopkins University Methods and system for epigenetic analysis
CN107779485B (zh) * 2016-08-24 2022-03-18 中国科学院分子细胞科学卓越创新中心 Cmd1酶催化的5-甲基胞嘧啶核酸的新修饰及其应用
EP4209598A1 (en) 2016-10-19 2023-07-12 The Chinese University of Hong Kong Gestational age assessment by methylation and size profiling of maternal plasma dna
TWI797095B (zh) 2016-10-24 2023-04-01 美商格瑞爾有限責任公司 腫瘤檢測之方法及系統
WO2018099418A1 (en) * 2016-11-30 2018-06-07 The Chinese University Of Hong Kong Analysis of cell-free dna in urine and other samples
EP4450648A3 (en) * 2016-12-13 2025-01-15 Bellwether Bio, Inc. Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample
EP4667587A2 (en) * 2017-01-11 2025-12-24 Quest Diagnostics Investments LLC Method for non-invasive prenatal screening for aneuploidy
RS65618B1 (sr) * 2017-01-24 2024-07-31 Bgi Genomics Co Ltd Postupak za utvrđivanje frakcije nukleinskih kiselina bez ćelija iz prethodno određenog izvora u biološkom uzorku
EP4421489B1 (en) 2017-01-25 2026-03-11 The Chinese University of Hong Kong Diagnostic applications using nucleic acid fragments
CN107247873B (zh) * 2017-03-29 2020-04-14 电子科技大学 一种差异甲基化位点识别方法
CA3063405A1 (en) * 2017-05-12 2018-11-15 President And Fellows Of Harvard College Universal early cancer diagnostics
US12227737B2 (en) 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
JP2020537487A (ja) * 2017-07-12 2020-12-24 ユニバーシティー ヘルス ネットワーク メチローム解析を用いる癌の検出及び分類
EP3652740A2 (en) * 2017-07-12 2020-05-20 ANDE Corporation Pattern recognition system
IL316163A (en) * 2017-07-26 2024-12-01 Univ Hong Kong Chinese Enhancement of cancer screening using cell-free viral nucleic acids
US20200263170A1 (en) 2017-09-14 2020-08-20 Grail, Inc. Methods for preparing a sequencing library from single-stranded dna
WO2019067973A1 (en) 2017-09-28 2019-04-04 Grail, Inc. ENRICHMENT OF SHORT NUCLEIC ACID FRAGMENTS IN THE PREPARATION OF SEQUENCING LIBRARIES
US11168356B2 (en) * 2017-11-02 2021-11-09 The Chinese University Of Hong Kong Using nucleic acid size range for noninvasive cancer detection
CN111989407B (zh) 2018-03-13 2024-10-29 格里尔公司 异常的片段检测及分类
JP7620803B2 (ja) 2018-03-15 2025-01-24 グレイル インコーポレイテッド 組織特異的メチル化マーカー
CN119753091A (zh) 2018-04-02 2025-04-04 格里尔公司 用于扩增与癌症相关联的cfDNA分子的化验板
JP7455757B2 (ja) * 2018-04-13 2024-03-26 フリーノーム・ホールディングス・インコーポレイテッド 生体試料の多検体アッセイのための機械学習実装
CN112218957B (zh) * 2018-04-16 2025-08-08 格里尔公司 用于确定在无细胞核酸中的肿瘤分数的系统及方法
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
US11932899B2 (en) * 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
CN109448789A (zh) * 2018-09-17 2019-03-08 上海派森诺生物科技股份有限公司 一种基于perl语言的种群特异SNP位点的自动化分析方法
IL281741B2 (en) 2018-09-27 2026-04-01 Grail Inc Methylation markers and a targeted methylation detection panel
CN109295230A (zh) * 2018-10-24 2019-02-01 福建翊善生物科技有限公司 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法
CA3120713A1 (en) 2018-11-21 2020-05-28 Avida Biomed, Inc. Methods for targeted nucleic acid library formation
KR20210113237A (ko) * 2018-12-19 2021-09-15 더 차이니즈 유니버시티 오브 홍콩 무 세포 dna 말단 특성
WO2020132572A1 (en) 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
EP3921445B1 (en) 2019-02-05 2024-09-04 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
WO2020163410A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
WO2020192680A1 (en) 2019-03-25 2020-10-01 The Chinese University Of Hong Kong Determining linear and circular forms of circulating nucleic acids
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
WO2020227100A1 (en) * 2019-05-03 2020-11-12 Cornell University Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes
CA3147613A1 (en) * 2019-08-19 2021-02-25 Chang-Seok Ki Method for detecting chromosomal abnormality by using information about distance between nucleic acid fragments
KR102452413B1 (ko) * 2019-08-19 2022-10-11 주식회사 지씨지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
GB201915469D0 (en) 2019-10-24 2019-12-11 Univ London Cancer detection methods
WO2021108654A1 (en) * 2019-11-27 2021-06-03 Grail, Inc. Systems and methods for evaluating longitudinal biological feature data
EP4097231B1 (en) 2020-01-31 2025-03-19 Agilent Technologies, Inc. Systems and methods for targeted nucleic acid capture
KR20220148196A (ko) * 2020-02-10 2022-11-04 팔로젠 인코포레이티드 나노포어 디바이스 및 이를 사용하여 하전된 입자들을 검출하고 분류하는 방법
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
AU2021228737A1 (en) 2020-02-28 2022-09-22 Grail, LLC. Identifying methylation patterns that discriminate or indicate a cancer condition
CN112662764A (zh) * 2020-03-17 2021-04-16 博尔诚（北京）科技有限公司 一种检测11种癌症的探针组合物
US12592321B2 (en) 2020-06-19 2026-03-31 University Health Network Cancer detection and classification using methylome analysis
RU2738675C1 (ru) * 2020-07-28 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов
IL302988A (en) * 2020-11-19 2023-07-01 Nucleix Ltd Detection of methylation changes in DNA samples using restriction enzymes and high-throughput sequencing
AU2021401813A1 (en) * 2020-12-17 2023-07-06 Dana-Farber Cancer Institute, Inc. Methods of cancer detection using extraembryonically methylated cpg islands
CN112813148A (zh) * 2021-02-02 2021-05-18 博淼生物科技（北京）有限公司 飞行时间质谱检测5-羟甲基胞嘧啶的方法
CN118302816A (zh) * 2021-09-28 2024-07-05 行动基因(智财)有限公司 甲基化生物标记选择装置及方法
KR20230059423A (ko) * 2021-10-26 2023-05-03 주식회사 지씨지놈 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법
CN118215743A (zh) * 2021-11-04 2024-06-18 通用诊断股份公司 用于制备用于基因测序的生物样品的系统和方法
GB2636510B (en) 2022-02-07 2026-02-18 Centre For Novostics Fragmentation for measuring methylation and disease
US20240150840A1 (en) * 2022-02-22 2024-05-09 Flagship Pioneering Innovations Vi, Llc Intra-individual analysis for presence of health conditions
CN115064211B (zh) * 2022-08-15 2023-01-24 臻和(北京)生物科技有限公司 一种基于全基因组甲基化测序的ctDNA预测方法及装置
CN115612723B (zh) * 2022-09-26 2023-07-14 广州女娲生命科技有限公司 植入前胚胎的筛选方法
WO2024112893A1 (en) * 2022-11-23 2024-05-30 Foundation Medicine, Inc. Systems and methods for tracking personalized methylation biomarkers for the detection of disease
WO2024203348A1 (ja) * 2023-03-31 2024-10-03 ソニーグループ株式会社 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法
CN118737268A (zh) * 2023-05-04 2024-10-01 杭州圣庭医疗科技有限公司 一种鉴定肿瘤组织来源的试剂盒的数据分析方法
CN117025753A (zh) * 2023-08-15 2023-11-10 广州女娲生命科技有限公司 检测染色体变异的方法和装置
CN117079822B (zh) * 2023-10-17 2024-01-02 北京大学第三医院（北京大学第三临床医学院） 一种妊娠早中期四因子预测胎儿脑损伤的系统

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927028B2 (en) * 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
EP1342794B1 (en) 2002-03-05 2005-12-14 Epigenomics AG Method and device for determination of tissue specificity of free floating DNA in bodily fluids
PL376971A1 (pl) 2002-11-19 2006-01-23 Amgen, Inc. Amplifikowane geny związane z rakiem
US20060183128A1 (en) 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
EP2290106B1 (en) * 2004-03-08 2018-01-03 Rubicon Genomics, Inc. Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
WO2006128192A2 (en) 2005-05-27 2006-11-30 John Wayne Cancer Institute Use of free circulating dna for diagnosis, prognosis, and treatment of cancer
US7754428B2 (en) * 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
TWI335354B (en) * 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
WO2008155549A2 (en) 2007-06-19 2008-12-24 Oncomethylome Sciences Sa Improved urine sample collecting and processing
LT2557517T (lt) 2007-07-23 2023-01-10 The Chinese University Of Hong Kong Nukleino rūgščių sekos disbalanso nustatymas
JP4347372B2 (ja) 2007-08-10 2009-10-21 トヨタ自動車株式会社 静電塗装装置
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8563242B2 (en) * 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
CA2775671A1 (en) * 2009-10-02 2011-04-07 Centre For Addiction And Mental Health Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids
LT3783110T (lt) * 2009-11-05 2023-01-25 The Chinese University Of Hong Kong Vaisiaus genomo analizė iš motinos biologinio mėginio
EA034241B1 (ru) 2009-11-06 2020-01-21 Те Чайниз Юниверсити Ов Гонконг Способ пренатальной диагностики дисбаланса последовательности
CA2786564A1 (en) * 2010-01-19 2011-07-28 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
DK2529032T3 (en) * 2010-01-26 2017-05-01 Nipd Genetics Ltd METHODS AND COMPOSITIONS FOR NON-INVASIVE PRE-NATIONAL DIAGNOSTICATION OF Fetal ANEUPLOIDITIES
EP2564340B1 (en) 2010-04-29 2020-01-08 The Regents of The University of California Pathway recognition algorithm using data integration on genomic models (paradigm)
GB201007944D0 (en) * 2010-05-12 2010-06-30 Univ Aberystwyth Methods
WO2011150075A2 (en) 2010-05-25 2011-12-01 The Johns Hopkins University Compositions and methods for detecting a neoplasia
WO2012012693A2 (en) * 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
CN103069006A (zh) * 2010-07-23 2013-04-24 艾索特里克斯遗传实验室有限责任公司 区别表达的胚胎或母源基因组区的鉴定及其用途
WO2012031329A1 (en) * 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
MX349568B (es) 2010-11-30 2017-08-03 Univ Hong Kong Chinese Deteccion de aberraciones geneticas o moleculares asociadas con el cancer.
BR122021021823B1 (pt) * 2012-09-20 2023-04-25 The Chinese University Of Hong Kong Método para determinar um primeiro perfil de metilação de uma amostra biológica de um organismo, e, meio de armazenamento de memória

Also Published As

Publication number Publication date
KR20230145530A (ko) 2023-10-17
IL299444A (en) 2023-02-01
EP4335929A3 (en) 2024-05-29
AU2025205087A1 (en) 2025-07-24
FI4056712T3 (fi) 2024-08-29
EP4335929A2 (en) 2024-03-13
TW202043483A (zh) 2020-12-01
CN117757932A (zh) 2024-03-26
MY187444A (en) 2021-09-22
JP6985753B2 (ja) 2021-12-22
PT2898100T (pt) 2018-02-26
EP3536807A1 (en) 2019-09-11
IL299444B1 (en) 2024-07-01
JP2024009833A (ja) 2024-01-23
KR20200085928A (ko) 2020-07-15
ES3060911T3 (en) 2026-03-30
ES2665273T3 (es) 2018-04-25
JP2025026936A (ja) 2025-02-26
PL4056712T3 (pl) 2024-12-02
HUE053822T2 (hu) 2021-07-28
ES2994426T3 (en) 2025-01-23
EP3839065A1 (en) 2021-06-23
JP7594817B2 (ja) 2024-12-05
EP3536807B1 (en) 2023-11-29
JP2015536639A (ja) 2015-12-24
CN104781422A (zh) 2015-07-15
CA3122779A1 (en) 2014-03-27
HK1206797A1 (en) 2016-01-15
AU2013317708B2 (en) 2017-08-03
EP2898100A4 (en) 2016-05-11
EP2898100A1 (en) 2015-07-29
JP6683752B2 (ja) 2020-04-22
EP4056712B1 (en) 2024-07-31
PL2898100T3 (pl) 2018-06-29
JP6317354B2 (ja) 2018-04-25
ES2862726T3 (es) 2021-10-07
PL2898100T5 (pl) 2023-11-06
CA2884066C (en) 2021-08-10
IL237495A0 (en) 2015-04-30
EP4056712A1 (en) 2022-09-14
EP3354747B1 (en) 2021-02-17
AU2022201026B2 (en) 2025-04-03
DK3354747T3 (da) 2021-04-19
KR102587176B1 (ko) 2023-10-06
FI3536807T3 (fi) 2024-02-01
WO2014043763A1 (en) 2014-03-27
AU2013317708A1 (en) 2015-04-09
TWI901957B (zh) 2025-10-21
DK4056712T3 (da) 2024-08-26
AU2013317708C1 (en) 2017-11-23
IL268512B2 (en) 2023-06-01
PL3354747T3 (pl) 2021-07-26
KR20220065034A (ko) 2022-05-19
EP2898100B9 (en) 2023-08-02
EP4335929B1 (en) 2026-01-21
HUE066054T2 (hu) 2024-07-28
AU2020200128A1 (en) 2020-01-30
SMT202100256T1 (it) 2021-05-07
CA2884066A1 (en) 2014-03-27
ZA201501772B (en) 2016-10-26
LT4056712T (lt) 2024-09-10
CN104781422B (zh) 2023-12-26
IL237495B (en) 2019-09-26
DK2898100T3 (en) 2018-02-26
KR20210120124A (ko) 2021-10-06
TW202334438A (zh) 2023-09-01
HUE068129T2 (hu) 2024-12-28
PL3536807T3 (pl) 2024-05-06
EP2898100B2 (en) 2023-05-10
HRP20240210T1 (hr) 2024-05-10
KR20150082228A (ko) 2015-07-15
HRP20241142T1 (hr) 2024-11-22
SI4056712T1 (sl) 2024-10-30
TWI707953B (zh) 2020-10-21
AU2020200128B2 (en) 2021-11-18
PH12022552061A1 (en) 2024-03-11
PT3354747T (pt) 2021-05-07
PL4335929T3 (pl) 2026-04-07
AU2017251832B2 (en) 2019-10-10
ES2665273T5 (es) 2023-10-02
HRP20210716T1 (hr) 2021-06-11
CY1124139T1 (el) 2022-05-27
NZ717423A (en) 2017-08-25
ES2969567T3 (es) 2024-05-21
JP2018121644A (ja) 2018-08-09
TWI806621B (zh) 2023-06-21
IL313451A (en) 2024-08-01
KR102148547B1 (ko) 2020-08-26
BR122021021823B1 (pt) 2023-04-25
TW201418474A (zh) 2014-05-16
PH12015500547A1 (en) 2015-05-04
JP2020108400A (ja) 2020-07-16
KR102390711B1 (ko) 2022-04-26
PT4056712T (pt) 2024-08-08
KR102307424B1 (ko) 2021-09-29
AU2022201026A1 (en) 2022-03-10
SG10201705198UA (en) 2017-07-28
DK2898100T4 (da) 2023-07-24
EP2898100B1 (en) 2017-11-22
EP3354747A1 (en) 2018-08-01
PT3536807T (pt) 2024-02-01
SG11201501927VA (en) 2015-04-29
BR112015006183B1 (pt) 2022-04-26
TW202305145A (zh) 2023-02-01
HK1257868A1 (en) 2019-11-01
IL299444B2 (en) 2024-11-01
EP4335929C0 (en) 2026-01-21
TWI640634B (zh) 2018-11-11
TWI784258B (zh) 2022-11-21
MY173356A (en) 2020-01-21
MX2015003571A (es) 2015-06-22
IL268512A (en) 2019-09-26
DK3536807T3 (da) 2024-02-05
MX360034B (es) 2018-10-19
LT3354747T (lt) 2021-04-12
NZ706269A (en) 2016-08-26
BR122021021825B1 (pt) 2022-05-24
JP2022031753A (ja) 2022-02-22
BR112015006183A2 (pt) 2017-07-04
AU2017251832A1 (en) 2017-11-16
TW201907013A (zh) 2019-02-16
HK1207124A1 (en) 2016-01-22
PH12015500547B1 (en) 2024-05-17

Similar Documents

Publication Publication Date Title
EA201500327A1 (ru) Неинвазивное определение метилома плода или опухоли по плазме
Vachon et al. Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk
WO2013132305A8 (en) Size-based analysis of fetal dna fraction in maternal plasma
WO2015048665A3 (en) Method to estimate the age of tissues and cell types based on epigenetic markers
WO2016138105A3 (en) Assays to determine dna methylation and dna methylation markers of cancer
EP4484572A3 (en) Identification and use of circulating nucleic acid tumor markers
BR112015011359A2 (pt) método para indicar uma presença ou não presença de câncer de próstata agressivo
MX2017014381A (es) Metodos terapeuticos y diagnosticos para cancer.
EA201500027A1 (ru) Мутационный анализ днк в плазме для детектирования рака
EA201400117A1 (ru) Способы и нуклеиновые кислоты для определения прогноза у больных раком
EA201491371A1 (ru) Соединение пиразинкарбоксамида
NZ748624A (en) Methods of selecting an individual who will benefit from treatment with a telomerase inhibitor using a formalin fixed paraffin embedded (ffpe) biological sample of solid tumor cancer cells
BR112016024143A2 (pt) tratamento de câncer
BR112015022977A2 (pt) métodos para predição de risco de metástase em melanoma cutâneo
CA2863427A1 (en) Use of pdgfr-.alpha. as diagnostic marker for papillary thyroid cancer
MX382589B (es) Determinación no invasiva del metiloma fetal o de tumor de plasma.
WO2016018524A8 (en) E2f4 signature for use in diagnosing and treating breast and bladder cancer
WO2019103421A3 (ko) 유전자의 cpg 메틸화 변화를 이용한 간암의 예후 또는 위험도를 평가하는 방법
BR102015015096A2 (pt) método de detecção in vitro de câncer de tireoide em um paciente, método in vitro de diferenciação entre câncer de tireoide e tecido de tireoide normal ou de lesões benignas de tireoide, uso de um conjunto de genes, método de obtenção de dados para direcionamento do tratamento do cancer de tireoide, kit laboratorial e dispositivo para classificar uma amostra biológica de glândula tireoide como maligna ou benigna
WO2013131087A3 (en) Methods and compositions for determining virus susceptibility to non-nucleoside reverse transcriptase inhibitors
RU2014128454A (ru) Способ определения вероятности рецидивирования рака молочной железы
EA201690354A1 (ru) Уровни экспрессии иммуноглобулинов в качестве биологического маркера для реакции на ингибитор протеасом
LI et al. Expression of EZH2 gene in cervical squamous carcinoma and its clinicopathologic significance
PE20142434A1 (es) Metodo para la identificacion del origen de un cancer de origen primario desconocido
ZHANG et al. Monitoring EGFR T790M mutations by Blocker PCR in plasma of advanced non-small-cell lung cancer patients with EGFR-TKI acquired resistance